{"id":775716,"date":"2023-08-04T18:56:17","date_gmt":"2023-08-04T22:56:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/"},"modified":"2023-08-04T18:56:17","modified_gmt":"2023-08-04T22:56:17","slug":"rani-therapeutics-to-participate-in-august-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/","title":{"rendered":"Rani Therapeutics to Participate in August Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN JOSE, Calif., Aug.  04, 2023  (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (\u201cRani Therapeutics\u201d or \u201cRani\u201d) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in three upcoming investor conferences in August 2023. These conferences include:\u00a0 \u00a0 \u00a0\u00a0<\/p>\n<p align=\"justify\">\n        <strong>BTIG Virtual Biotechnology Conference<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Date: Monday, August 7<sup>th<\/sup> at 2:00pm E.T.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Format: Virtual Presentation and 1&#215;1 Investor Meetings\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/>Presenter: Chief Executive Officer, Talat Imran<\/p>\n<p align=\"justify\">\n        <strong>Wedbush PacGrow Healthcare Conference<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Date: Tuesday, August 8, 2023 in New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Format: 1&#215;1 Investor Meetings<\/p>\n<p align=\"justify\">\n        <strong>Canaccord Genuity Annual Growth Conference<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Date: Thursday, August 10, 2023 at 1:00pm E.T. in Boston, MA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Format: Fireside Chat and 1&#215;1 Investor Meetings \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Presenter: Chief Executive Officer, Talat Imran<\/p>\n<p align=\"justify\">Interested parties can access the live webcasts for these conferences (if available) from the Investor Relations section of the company&#8217;s website at www.ranitherapeutics.com. The webcast replays will be available after the conclusion of the respective presentations.<\/p>\n<p align=\"justify\">\n        <strong>About Rani Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">Rani Therapeutics is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. Rani has developed the RaniPill\u00ae capsule, which is a novel, proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. Rani is progressing two RaniPill\u00ae capsules, the RaniPill\u00aeGO and the RaniPill\u00aeHC. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using RaniPill\u00ae capsule technology. For more information, visit ranitherapeutics.com.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NnV4B3C6nGj-dVPSbb2egHGGyLIXJIBPSNgVGtXI9BZ5yeVGII6XrmP2eKjhY9wCFtoDeWEirUBfXv_O-yyhhSI6MdniZTy1AFmPeM7MnhWsv-A31xJIyW98oUQ1404I\" rel=\"nofollow noopener\" target=\"_blank\">investors@ranitherapeutics.com<\/a>\n      <\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oVWFdQVK2Rr4uS2JsQk7h1bMdRXrO8NG6TEjhQJ6oCh0a45tukxxhP5HepxqNJmVhn0OKAeKFfk1PrkhyD9rqUPG-wEN0PgSEOy0XoNCFeo0S407xWiXQ6fAwE22Ru4c\" rel=\"nofollow noopener\" target=\"_blank\">media@ranitherapeutics.com<\/a>\n      <\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MjgyM2I3Y2YtZTQwOS00NmM3LThlYTAtZDdkOWFhZTViM2I0LTEyMjAyNTI=\/tiny\/Rani-Therapeutics-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (\u201cRani Therapeutics\u201d or \u201cRani\u201d) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in three upcoming investor conferences in August 2023. These conferences include:\u00a0 \u00a0 \u00a0\u00a0 BTIG Virtual Biotechnology Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Monday, August 7th at 2:00pm E.T.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Virtual Presentation and 1&#215;1 Investor Meetings\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Presenter: Chief Executive Officer, Talat Imran Wedbush PacGrow Healthcare Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Tuesday, August 8, 2023 in New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: 1&#215;1 Investor Meetings Canaccord Genuity Annual Growth Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Thursday, August 10, 2023 at 1:00pm E.T. in Boston, MA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside Chat and 1&#215;1 Investor Meetings \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presenter: Chief Executive Officer, Talat Imran Interested parties can access &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rani Therapeutics to Participate in August Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-775716","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rani Therapeutics to Participate in August Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rani Therapeutics to Participate in August Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (\u201cRani Therapeutics\u201d or \u201cRani\u201d) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in three upcoming investor conferences in August 2023. These conferences include:\u00a0 \u00a0 \u00a0\u00a0 BTIG Virtual Biotechnology Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Monday, August 7th at 2:00pm E.T.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Virtual Presentation and 1&#215;1 Investor Meetings\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Presenter: Chief Executive Officer, Talat Imran Wedbush PacGrow Healthcare Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Tuesday, August 8, 2023 in New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: 1&#215;1 Investor Meetings Canaccord Genuity Annual Growth Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Thursday, August 10, 2023 at 1:00pm E.T. in Boston, MA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside Chat and 1&#215;1 Investor Meetings \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presenter: Chief Executive Officer, Talat Imran Interested parties can access &hellip; Continue reading &quot;Rani Therapeutics to Participate in August Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-04T22:56:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rani Therapeutics to Participate in August Investor Conferences\",\"datePublished\":\"2023-08-04T22:56:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/\"},\"wordCount\":263,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/\",\"name\":\"Rani Therapeutics to Participate in August Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=\",\"datePublished\":\"2023-08-04T22:56:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rani-therapeutics-to-participate-in-august-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rani Therapeutics to Participate in August Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rani Therapeutics to Participate in August Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Rani Therapeutics to Participate in August Investor Conferences - Market Newsdesk","og_description":"SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) &#8212; Rani Therapeutics Holdings, Inc. (\u201cRani Therapeutics\u201d or \u201cRani\u201d) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that the Company will participate in three upcoming investor conferences in August 2023. These conferences include:\u00a0 \u00a0 \u00a0\u00a0 BTIG Virtual Biotechnology Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Monday, August 7th at 2:00pm E.T.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Virtual Presentation and 1&#215;1 Investor Meetings\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Presenter: Chief Executive Officer, Talat Imran Wedbush PacGrow Healthcare Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Tuesday, August 8, 2023 in New York, NY\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: 1&#215;1 Investor Meetings Canaccord Genuity Annual Growth Conference\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Date: Thursday, August 10, 2023 at 1:00pm E.T. in Boston, MA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Format: Fireside Chat and 1&#215;1 Investor Meetings \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Presenter: Chief Executive Officer, Talat Imran Interested parties can access &hellip; Continue reading \"Rani Therapeutics to Participate in August Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2023-08-04T22:56:17+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rani Therapeutics to Participate in August Investor Conferences","datePublished":"2023-08-04T22:56:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/"},"wordCount":263,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/","name":"Rani Therapeutics to Participate in August Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=","datePublished":"2023-08-04T22:56:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg4ODA0MSM1NzM5MjAwIzIyMDg2OTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rani-therapeutics-to-participate-in-august-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rani Therapeutics to Participate in August Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775716","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=775716"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/775716\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=775716"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=775716"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=775716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}